ChemicalBook >> CAS DataBase List >>XGZZHZMWIXFATA-VQNNHZPYSA-N

XGZZHZMWIXFATA-VQNNHZPYSA-N

XGZZHZMWIXFATA-VQNNHZPYSA-N structure

CAS No.: 163712-68-3

Chemical Name:: XGZZHZMWIXFATA-VQNNHZPYSA-N

Synonyms: XGZZHZMWIXFATA-VQNNHZPYSA-N;Controlled Substance(Nalfurafine Impurity 4);2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (Z)- (9CI);(Z)-N-((4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3-(furan-3-yl)-N-methylacrylamide

CBNumber:: CB83395752

Molecular Formula:: C28H32N2O5

Molecular Weight:: 476.57

MDL Number:

MOL File:: 163712-68-3.mol

Last updated:2023-05-15 10:43:27

Request For Quotation

XGZZHZMWIXFATA-VQNNHZPYSA-N Properties

Boiling point	700.7±60.0 °C(Predicted)
Density	1.41±0.1 g/cm3(Predicted)
pka	9.37±0.60(Predicted)

XGZZHZMWIXFATA-VQNNHZPYSA-N Chemical Properties,Uses,Production

Uses

2Z-Nalfurafine-d3 is the labeled analogue of 2Z-Nalfurafine (N255610), a geometric isomer of Nalfurafine (N255600), a on-narcotic opioid drug for intractable itch caused by hemodialysis. It showed significant opioid κ-agonist activity and induced neither aversion nor preference in rats on the CPP (Conditioned Place Preference) test. Nalfurafine is a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients.

XGZZHZMWIXFATA-VQNNHZPYSA-N Preparation Products And Raw materials

Raw materials

Preparation Products

XGZZHZMWIXFATA-VQNNHZPYSA-N Suppliers

Global( 14)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
QUALITY CONTROL SOLUTIONS LTD.	+86-0755-66853366 +86-13670046396	export03@qcsrm.com	China	24342	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18234	56
TOSUN PHARM	020-61855200 13326451905	260366801@qq.com	China	7905	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736	2853117764@qq.com	China	10000	58
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44918	58
HX Pharmaceutical technology co., LTD	15671363360	494267389@qq.com	China	5000	58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd	18502726233; 18502726233	3641133981@qq.com	China	9713	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016; 18162595016	3287908757@qq.com	China	9119	58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd	020-18102736 18102736234	LK@zlstandards.com	China	8206	58
Nantong Hanfang Biotechnology Co. , Ltd.	hanfangpharma@126.com; 18616537568	hanfangpharma@126.com	China	29964	58

Supplier	Advantage
QUALITY CONTROL SOLUTIONS LTD.	58
ChemStrong Scientific Co.,Ltd	56
TOSUN PHARM	58
Hubei Xinyang Medical Technology Co., Ltd	58
Energy Chemical	58
HX Pharmaceutical technology co., LTD	58
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd	58
Nantong Hanfang Biotechnology Co. , Ltd.	58

XGZZHZMWIXFATA-VQNNHZPYSA-N 2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (Z)- (9CI) (Z)-N-((4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl)-3-(furan-3-yl)-N-methylacrylamide Controlled Substance(Nalfurafine Impurity 4) 163712-68-3